Biomedical subjects

D M DeLong

Publications and source records attributed to D M DeLong.

At least 19 recordsLinked to original sources

PubMed2000

Pelvic CT morphometry in Down syndrome: implications for prenatal US evaluation--preliminary results.

PURPOSE: To characterize pelvic morphometric differences in patients with and those without Down syndrome by using computed tomography (CT) and to determine useful indexes for ultrasonographic (US) evaluation. MATERIALS AND METHODS: Pelvic CT scans in seven patients with Down syndrome and in 27 patients without Down syndrome were reviewed. Iliac angle, iliac length, sacroiliac joint angle, and anterior iliac wing separation were measured at superior, middle, and inferior transverse sacral levels. The effects of chromosomal status and transverse level were evaluated statistically. RESULTS: Significant differences were found for mean iliac angle (P < .007) and length (P < .005) between patients without Down syndrome (angle, 75 degrees; length, 8.4 cm) and those with Down syndrome (angle, 82 degrees; length, 7.5 cm). Depending on the level of measurement, variations in iliac angle between patients without and those with Down syndrome were as much as 13 degrees and 15 degrees, respectively, and variations in length were as much as 1.6 cm and 0.9 cm, respectively. The greatest differences were at the middle sacral level. Sacroiliac joint angle and the anterior iliac wing separation were not different between groups. CONCLUSION: Patients with Down syndrome had a larger mean iliac angle and a shorter mean iliac length. The most pronounced differences were at the middle sacral level, which suggests that this may be the optimal level for measuring these parameters at prenatal US.

Down Syndrome↗

PubMed2000

Variability of Doppler US measurements along the common carotid artery: effects on estimates of internal carotid arterial stenosis in patients with angiographically proved disease.

PURPOSE: To determine the effect of variability of common carotid arterial (CCA) velocities on velocity ratios used to assess internal carotid arterial (ICA) stenosis. MATERIALS AND METHODS: Doppler ultrasonographic (US) velocity measurements were obtained at three levels in the CCA and in the carotid bulb and ICA in all patients referred for carotid US between September 1996 and October 1997. Only ICAs (n = 98, in 57 patients) without ipsilateral CCA disease at angiography were analyzed. The range of CCA peak systolic velocities (PSVs) and end diastolic velocities (EDVs) and velocity ratios were calculated for each CCA measurement. For each ICA/CCA velocity ratio, receiver operating characteristic analysis was performed. RESULTS: CCA PSV and EDV ranges averaged 23.1 cm/sec +/- 15.7 (SD) and 5.1 cm/sec +/- 3.6, respectively. For a given side, the difference averaged 1.0 +/- 1.3 for PSV ratios and 2.7 +/- 6.9 for EDV ratios, depending on where CCA measurements were taken. By using a threshold of 60% stenosis as indication for endarterectomy, variability in CCA velocities could have altered recommendations in 16 (28%) of 57 patients. Receiver operating characteristic analysis showed that ratios made by using the three CCA velocities or their mean were not significantly different. CONCLUSION: Variability in velocity measurements along the course of the CCA in patients with ICA disease can be substantial and can result in inaccuracies in assessment of carotid stenosis.

Aged↗

PubMed2000

Hepatic parenchymal enhancement during triple-phase helical CT: can it be used to predict which patients with breast cancer will develop hepatic metastases?

PURPOSE: To evaluate the efficacy of hepatic enhancement characteristics for identification of patients with breast cancer who are at risk for future hepatic metastases. MATERIALS AND METHODS: Triple-phase helical computed tomography (CT) was performed in 60 patients with known breast cancer without visible hepatic metastases. Peak hepatic attenuation and enhancement, and attenuation and enhancement at 25 and 30 seconds were obtained. Ratios of hepatic attenuation or enhancement at 25 and 30 seconds to peak hepatic attenuation or enhancement were calculated. A Wilcoxon rank sum test was used to compare patients with and those without subsequent hepatic metastases. RESULTS: During a mean 18-month follow-up, 18 patients (30%) developed hepatic metastases. Decreases in peak hepatic attenuation and enhancement and increases in hepatic attenuation and enhancement ratios at 25 and 30 seconds were seen in patients who developed metastases compared with those who did not (P < .05). When corrected for chemotherapy interval, these differences were not statistically significant. Using a threshold value of 0.40 or more for the enhancement ratio at 30 seconds resulted in sensitivity of 28%, specificity of 92%, and accuracy of 55%. CONCLUSION: Patients with breast cancer who develop subsequent hepatic metastases have higher relative hepatic arterial perfusion during triple-phase CT; however, after correction for chemotherapy interval, this difference was not statistically significant. Threshold values cannot be used reliably to identify patients who will develop metastases.

Adult↗

PubMed2000

Normal fetal pelvis: important factors for morphometric characterization with US.

PURPOSE: To prospectively evaluate iliac angle and iliac length in a large number of normal fetuses and to identify factors that may influence these measurements. MATERIALS AND METHODS: At antenatal ultrasonography (US) in 356 fetuses, the iliac angle and iliac length were measured at two axial levels (superior and inferior). In mixed linear models, the statistical significance and magnitude of effect on the measurement of iliac angle and iliac length were estimated for gestational age, fetal sex, maternal diabetes status, axial level, and spine position relative to the transducer. RESULTS: Statistically significant effects were found for gestational age, axial level, and spine orientation but not for fetal sex or maternal diabetes status. The iliac angle was found to decrease by 15.7 degrees from the superior to inferior portion of the pelvis, decrease by approximately 0.37 degrees /wk, and decrease by as much as 15.6 degrees when the spine is directed to the side. Iliac length was found to increase by 0.8 mm/wk from 13 weeks to term, decrease by 1.2 mm from the superior to the inferior portion of the pelvis, and increase by as much as 1.29 mm when the spine is not directly subjacent to the transducer. CONCLUSION: The axial level of measurement, gestational age, and spine orientation must be accounted for if these morphometric indexes are used to discriminate fetuses with and those without Down syndrome.

Amniocentesis↗

PubMed2000

Nonenhanced helical CT and US in the emergency evaluation of patients with renal colic: prospective comparison.

PURPOSE: To compare nonenhanced helical computed tomography (CT) with ultrasonography (US) for the depiction of urolithiasis. MATERIALS AND METHODS: During 9 months, 45 patients (mean age, 44 years; mean weight, 92.5 kg) prospectively underwent both nonenhanced helical CT (5-mm collimation; pitch of 1.5) and US of the kidneys, ureters, and bladder. US evaluation included a careful search for ureteral calculi. Presence of calculi and obstruction and incidental diagnoses were recorded. Clinical, surgical, and/or imaging follow-up data were obtained in all patients. The McNemar test was used to compare groups. RESULTS: Diagnoses included 23 ureteral calculi and one each of renal cell carcinoma, appendicitis, ureteropelvic junction obstruction, renal subcapsular hematoma, cholelithiasis, medullary calcinosis, and myelolipoma. CT depicted 22 of 23 ureteral calculi (sensitivity, 96%). US depicted 14 of 23 ureteral calculi (sensitivity, 61%). Differences in sensitivity were statistically significant (P: =.02). Specificity for each technique was 100%. When modalities were compared for the detection of any clinically relevant abnormality (eg, unilateral hydronephrosis and/or urolithiasis in patients with an obstructing calculus), sensitivities of US and CT increased to 92% and 100%, respectively. One case of appendicitis was missed at US, whereas medullary calcinosis and myelolipoma were missed at CT. CONCLUSION: Nonenhanced CT has a higher sensitivity for the detection of ureteral calculi compared with US.

Adult↗

PubMed2000

Evaluation of pseudoenhancement of renal cysts during contrast-enhanced CT.

OBJECTIVE: The purpose of our study was to evaluate renal cyst pseudoenhancement during helical CT in a phantom model and in patients. MATERIALS AND METHODS: Iodine baths containing water-filled spheres and cylinders were constructed to simulate cysts in enhancing renal parenchyma. Iodine concentration, cyst size and location, collimation, and peak kilovoltage were varied and cyst attenuation was measured. Data were analyzed with the mixed linear models and Mantel-Haenszel tests. Subsequently, a paired t test compared CT attenuation values before and after contrast material enhancement in 40 patients with 68 renal cysts (radiographic stability >3 months). RESULTS: The attenuation values of phantom cysts increased when placed in a contrast media bath (p = 0.001). The increase in attenuation values became more pronounced with increasing iodine concentrations, decreasing peak kilovoltage, and smaller sphere sizes. In patients, mean cyst attenuation increased 3.4 +/- 6.2 H after administration of contrast material (p = 0.00002). The attenuation did not increase more than 10 H in any of the 37 cysts larger than 2 cm found in patients. Eight (26%) of the 31 cysts smaller than 2 cm found in patients increased by at least 10 H. CONCLUSION: In a phantom model, at simulated physiologic levels of renal enhancement, cysts may pseudoenhance by more than 10 H. Similarly, in patients, cysts may also pseudoenhance; however, most pseudoenhancement does not exceed 10 H. In patients, pseudoenhancement of at least 10 H is more likely in cysts smaller than 2 cm.

Humans↗

PubMed2000

Comparison of sonographic and CT guidance techniques: does CT fluoroscopy decrease procedure time?

OBJECTIVE: Procedure times for percutaneous biopsies were compared for various guidance techniques including helical CT, CT fluoroscopy, sonography with an attached needle guide, and freehand sonography with computer guidance. MATERIALS AND METHODS: Three interventional radiologists experienced in CT- and sonographically guided procedures performed biopsies on a phantom model. The phantom simulated hepatic metastases of various sizes and depths with subcostal or intercostal locations. Lesion sizes were 7, 10, and 20 mm, at 3- and 7-cm depths. Using self-aspirating needles, two passes were performed in each lesion. Mean procedure time per biopsy pass was calculated. A two-tailed Student's t test was used to compare guidance techniques. RESULTS: Mean procedure time per biopsy pass for the four guidance techniques was sonography with a needle guide, 36+/-9 sec; sonography with computer guidance, 43+/-10 sec; helical CT, 146+/-42 sec; and CT fluoroscopy, 50+/-18 sec. CT fluoroscopy required 2.6+/-1.0 sec per biopsy. Helical CT required more procedure time than sonography with a needle guide, CT with computer guidance, and CT fluoroscopy (p < 0.0001). Sonography with a needle guide required less procedure time than sonography with computer guidance (p < 0.002) and CT fluoroscopy (p = 0.0003). Procedure times for CT fluoroscopy and sonography with computer guidance were not statistically different (p = 0.06). CT and sonographic guidance were equally effective regardless of lesion size, depth, or location. CONCLUSION: Traditional sonographic biopsy techniques are faster and more cost-effective than traditional CT techniques; however, CT fluoroscopy offers the localization advantages of CT with improved procedure times.

Abdomen↗

PubMed2000

The effect of aging on the apparent diffusion coefficient of normal-appearing white matter.

OBJECTIVE: The purpose of our study was to test the hypothesis that the apparent diffusion coefficient (ADC) of normal-appearing white matter increases with advancing age. SUBJECTS AND METHODS: We selected 38 patients with normal MR imaging findings from 332 patients undergoing clinical MR imaging. Diffusion-weighted MR imaging was performed with diffusion gradients applied in three orthogonal directions. For each patient, the average ADC on trace-weighted diffusion images of white matter at prespecified regions of interest and at the thalamus were compared with the patient's age. RESULTS: For the white matter, ADC sorted by patient age in decades increased with advancing age. Patients at least 60 years old had significantly higher ADC (0.769 +/- 0.019 mm(2)/sec x 10(-3)) than patients less than 60 years old (0.740 +/- 0.013 mm(2)/sec x 10(-3)) (p < 0.001). Comparison of individual white matter ADC and age showed a significant increase with advancing age (p < 0.0001). For the thalamus, the average ADC among patients at least 60 years old (0.766 +/- 0.015 mm(2)/sec x 10(-3)) exceeded the average ADC for patients less than 60 years old (0.745 +/- 0.022 mm(2)/sec x 10(-3)) (p < 0.05). However, comparison of individual thalamic ADC and patient ages, although showing a trend to higher ADC with increasing age, did not reach statistical significance (p = 0.06). CONCLUSION: Advancing age is associated with a small but statistically significant increase of water diffusibility in human white matter. A similar trend was present in the thalamus. These increases may reflect mild structural changes associated with normal aging.

Adult↗

PubMed1999

Intracerebral hemorrhage outcome: apolipoprotein E genotype, hematoma, and edema volumes.

We investigated whether early hematoma or edema volumes could explain the adverse association between APOE epsilon4 and survival in intracerebral hemorrhage. Among 102 patients, epsilon4 carriers had a higher mortality rate than non-epsilon4 carriers (38 versus 24%, p = 0.05). Nonsurvivors had larger hematoma (75.5 cm3 versus 27.1 cm3, p<0.001) and edema volumes (37.5 cm3 versus 17.1 cm3, p<0.01), but these were not associated with epsilon4 after adjusting for race, age, and type of hemorrhage.

Aged↗

PubMed1999

Comparison of unenhanced, hepatic arterial-dominant, and portal venous-dominant phase helical CT for the detection of liver metastases in women with breast carcinoma.

OBJECTIVE: The purpose of this study was to evaluate triple-phase helical CT for detection of hepatic metastases from breast carcinoma. SUBJECTS AND METHODS: Breast cancer patients were studied prospectively with triple-phase helical CT in 300 consecutive examinations. Hepatic arterial-dominant and portal venous-dominant phase scans were initiated at 20 and 65 sec, respectively, after IV injection of 175 ml of iopamidol (30 mg/ml) at 5 ml/sec. Three independent observers each reviewed 200 cases of the portal venous-dominant phase for lesion number, conspicuity, and attenuation. Subsequently, portal venous-dominant phase images were reevaluated in conjunction with hepatic arterial-dominant phase or unenhanced images. RESULTS: Hepatic metastases were identified in 79 (26%) of 300 cases. Lesions detected on portal venous-dominant, hepatic arterial-dominant, and unenhanced images were as follows: observer 1, n = 198, 164, and 171; observer 2, n = 254, 233, and 233; and observer 3, n = 291, 270, and 276 (p > .05). The mean total lesion count was 387, with more lesions detected on portal venous-dominant phase than on either hepatic arterial-dominant phase or unenhanced images (p < .001 and p < .0001, respectively). For individual observers, 10-26% of lesions were hypervascular on hepatic arterial-dominant phase images. Two to 4% of lesions were identified only on hepatic arterial-dominant phase or unenhanced images. However, in these few cases, the lesions either were false-positives or were seen in conjunction with additional metastases on portal venous-dominant images. CONCLUSION: Routine use of triple-phase CT in patients with breast carcinoma may not be warranted: Addition of the hepatic arterial-dominant phase or unenhanced images revealed few additional lesions in our group of 300 patients.

Adult↗

PubMed1999

Optimizing contrast-enhanced abdominal CT in infants and children using bolus tracking.

OBJECTIVE: Manual administration of IV contrast material results in unpredictable injection rates. Our purpose was to determine the effect of bolus tracking on overall abdominal helical CT scan quality, particularly on hepatic enhancement, in children with manually administered contrast media. MATERIALS AND METHODS: We compared 33 abdominal helical CT scans of 29 children in whom bolus tracking was used with 22 CT scans of a control group of 21 children in whom bolus tracking was not used. All contrast material was administered by manual injection. Qualitative assessment was made of organ and vessel enhancement and overall scan appearance. Quantitative assessment using region-of-interest cursors was performed at three anatomic levels, and the results for the two groups of children were compared. RESULTS: Qualitative comparison of enhancement parameters between the bolus tracking group (number given first) and the control group (number given second) yielded the following: splenic artifact in 9% versus 23% (p = .24); inferior vena cava flow artifact in 3% versus 27% (p = .01); scanning during the nephrographic phase in 89% versus 59% (p = .02); and good quality grade in 79% versus 64% (p = .23). Significantly greater hepatic enhancement (as measured in mean Hounsfield units) was achieved in the bolus tracking group than in the control group at the superior (48.5 versus 28.6; p < .001), middle (47.9 versus 32.3; p < .001), and inferior (48.2 versus 36.5; p = .01) levels. Hepatic enhancement increased significantly from the superior to the inferior level in the control group (p < .02), whereas enhancement was homogeneous in the bolus tracking group (p > .50). CONCLUSION: Bolus tracking provides improved contrast enhancement, including significantly greater hepatic enhancement, during abdominal helical CT in children in whom the rate of injection of contrast material is unpredictable.

Child↗

PubMed1999

Indeterminate findings on imaging-guided biopsy: should additional intervention be pursued?

OBJECTIVE: Our purpose was to determine the outcome of patients in whom the results of imaging-guided biopsies were indeterminate and to examine factors that may affect outcome. MATERIALS AND METHODS: During a 25-month period, 619 consecutive imaging-guided biopsies (CT, n = 268 [43%]; sonography, n = 351 [57%]) were performed on abdominal lesions. Of these biopsies, findings from 454 biopsies (73%) were positive for malignancy, findings from 21 biopsies (3%) yielded a benign diagnosis, and findings from 15 biopsies (2%) were nondiagnostic. Findings from the remaining 129 biopsies (21%) were considered indeterminate because the pathologic diagnosis revealed benign tissue, inflammation, stromal elements, or atypical cells. The frequency of malignancy in lesions of patients in this indeterminate group was determined. RESULTS: Thirty-eight of the 129 patients were lost to follow-up. Of the remaining 91 patients, 55 (60%) had true-negative (benign) results, and 36 (40%) had false-negative (malignant) results. A history of malignancy had no significant effect on the true- or false-negative rate (p = .799). However, the guidance technique had a statistically significant effect: CT and sonographic guidance yielded 25 (49%) and 11 (28%) false-negative results, respectively (p = .037). The number of needle passes, needle type and gauge, and biopsy site did not have a statistically significant correlation with the false-negative rate. The presence of atypical cells in the cytologic aspirate was highly predictive, with a 71% false-negative rate (p = .008). CONCLUSION: We found a high incidence of malignancy (40%) in lesions deemed indeterminate at the time of biopsy. Thus, close follow-up or additional intervention should be pursued in such cases. Sonographic guidance resulted in a statistically significant decrease in the false-negative rate when compared with CT guidance; however, a history of malignancy, the biopsy site, the needle gauge and type, and the number of passes did not have a significant effect on the false-negative rate.

Biopsy, Needle↗

PubMed1999

Sonographically guided compression repair of pseudoaneurysms: further experience from a single institution.

OBJECTIVE: Our purpose was to perform a comprehensive review of our experience with compression of postcatheterization groin pseudoaneurysms. MATERIALS AND METHODS: Two hundred eighty-one patients underwent 306 sonographically guided compression procedures on 297 groin pseudoaneurysms after femoral artery catheterization. The medical records, cardiac catheterization reports, and sonographic images were reviewed to determine patient demographics, type of catheterization procedure performed, sheath size, access site, interval from sheath removal to compression, anticoagulation status, pseudoaneurysm dimensions, complications, and follow-up information. Statistical analysis was performed using Pearson's chi-square and Kendall tau tests. RESULTS: The success rate for the initial compression attempt was 72.1%. Of the 83 failed compression attempts, 12 patients underwent a second attempt, of which seven attempts were successful. Therefore, counting both first and second attempts, the success rate was 74.4%. A strong negative correlation existed between anticoagulation status and success, with a 70% failure rate in patients with anticoagulated blood. Smaller pseudoaneurysm size was strongly correlated with success. Of the 83 failed cases, 49 ultimately underwent surgical repair. Eleven complications (3.6%) occurred, including three patients with rupture during compression. No deaths occurred as a result of compression repair. CONCLUSION: We conclude that sonographically guided pseudoaneurysm compression repair is an effective alternative to surgical repair, though nearly one third of compression attempts will fail and most of those patients will ultimately require surgery. The procedure is less effective when the patient's blood is anticoagulated and when the pseudoaneurysm is large. The procedure carries an overall complication rate of 3.6% and a risk for rupture of 1%.

Aged↗

PubMed1998

Carcinoid metastases to the liver: role of triple-phase helical CT.

PURPOSE: To evaluate triple-phase helical computed tomography (CT) of carcinoid liver metastases. MATERIALS AND METHODS: Triple-phase helical CT was performed in 31 patients with proved carcinoid liver metastases. Hepatic arterial-dominant phase (HAP) and portal venous-dominant phase (PVP) images were obtained 20 and 70 seconds after intravenous iopamidol injection. Four independent readers reviewed each phase for lesion number, conspicuity, and attenuation relative to liver. Three readers reviewed each phase to determine which phase best showed the lesions. RESULTS: The lesions detected by readers 1-4 were as follows: noncontrast phase, 164, 177, 204, and 229 lesions; HAP, 178, 177, 214, and 238 lesions; and PVP, 180, 189, 215, and 250 lesions (P > .05). On HAP images, readers found that 80, 73, 96, and 102 lesions were hyperattenuating. Consensus indicated there were 206 focal lesions. Of these 206 lesions, 72, 72, and 62 lesions were best seen on the noncontrast phase, HAP, and PVP images, respectively. Six, 28, and six lesions were seen only on the noncontrast phase, HAP, and PVP images, respectively. Two patients had lesions seen only on the HAP images. CONCLUSION: The HAP and, to a lesser extent, the noncontrast phase provide added value in evaluating carcinoid liver metastasis.

Carcinoid Tumor↗

PubMed1998

Dynamic helical CT of the abdomen: prospective comparison of pre- and postprandial contrast enhancement.

PURPOSE: To investigate effects of a liquid meal on contrast material enhancement at dynamic helical computed tomography (CT). MATERIALS AND METHODS: Twenty healthy, fasting subjects underwent intravenous injection of nonionic contrast material at 4 mL/sec. Axial CT sections were obtained at a single level 15 seconds after injection, then every 5 seconds for 2 minutes. This protocol was repeated 1 week later, after ingestion of a 360-calorie liquid meal. Hepatic, splenic, and aortic attenuation were measured before and after contrast material administration. Peak enhancement level, time to peak enhancement, slope of hepatic enhancement, and hepatic, splenic, and aortic enhancement ratios were determined. RESULTS: Postprandial time to peak enhancement was 4.4 seconds earlier than preprandial (59.6 seconds +/- 9.0 [1 standard deviation] vs 64.0 seconds +/- 9.5; P < .02). No differences in maximum attenuation were found (P > .27). Postprandial maximum slope of hepatic enhancement and temporal and quantitative enhancement characteristics in aorta and spleen did not significantly differ. Postprandial hepatic-to-splenic enhancement ratios increased (P = .04), and aortic-to-hepatic ratios decreased (P = .01). Aortic-to-splenic ratios did not differ (P = .45). CONCLUSION: A liquid meal before intravenous injection of contrast material produces more rapid peak hepatic enhancement, with slightly increased relative hepatic enhancement. A patient's dietary status, however, should not influence the CT protocol.

Adult↗

PubMed1998

Abdominal percutaneous interventional procedures: comparison of CT and US guidance.

PURPOSE: To compare ultrasound (US) with computed tomography (CT) as a guidance modality for percutaneous interventional procedures. MATERIALS AND METHODS: A database of abdominal interventional procedures was reviewed for the 6 months preceding and 6 months after the opening of a dedicated US interventional suite. Changes in the number and type of procedures performed, room time, number of needle passes, and complication rates were calculated. RESULTS: In the first 6 months, 305 interventional procedures (138 tissue biopsies and 167 fluid aspirations) were performed (CT guidance in 87% [n = 120] and 95% [n = 159], respectively). In the 6 months after installation of the suite, 395 procedures (195 tissue biopsies and 200 fluid aspirations) were performed (US guidance in 76% [n = 148] and 34% [n = 67], respectively). The largest increase in US utilization was for guidance of tissue biopsies, rising from 6% (18 of 305) to 37% (148 of 395) of all procedures. Room time was significantly less for US-guided procedures (mean US room time, 77 minutes +/- 33 [1 standard deviation]; mean CT room time, 99 minutes +/- 38; P < .0001). CONCLUSION: US guidance often allows performance of quicker, more accurate procedures than does CT guidance, probably because of its real-time capabilities.

Abdomen↗

PubMed1998

Doppler sonography of the portal vein and hepatic artery: measurement of a prandial effect in healthy subjects.

PURPOSE: To determine if the prandial effect outweighs variability in the measurement of portal venous blood flow and hepatic arterial resistive index. MATERIALS AND METHODS: Fourteen healthy adult volunteers fasted overnight. For eight of the subjects, two sonographers performed three determinations of portal venous blood flow and hepatic arterial resistive index before and 30 minutes after a liquid meal (5 mg per kilogram of body weight). In the remaining six volunteers, determinations were made at the same time intervals but without a meal. The sonographers were blinded to on-screen measurements and the subject's prandial status. RESULTS: For subjects examined after the meal by sonographers A and B, respectively, portal venous blood flow increased from 144.2 to 201.7 mL/min and from 209.2 to 331.9 mL/min and hepatic arterial resistive index increased from 0.70 to 0.77 and from 0.67 to 0.78. After repeated-measures analysis of variance, ingestion of a meal was estimated to increase portal venous blood flow by 96.3 mL/min (P < .001)--a change in sonographers could affect the measurement by 76.7 mL/min (P < .001)--and to increase hepatic arterial resistive index by 0.089 (P < .001)--a change in sonographers did not affect the measurement (P > .1). CONCLUSION: The prandial effect on portal venous blood flow is only marginally greater than the interobserver variation in the measurement. Hepatic arterial resistive index also increases after a meal, but interobserver differences between sonographers are minimal; therefore, it is a more robust measurement.

Adult↗

PubMed1998

Helical liver CT with computer-assisted bolus-tracking technology: is it possible to predict which patients will not achieve a threshold of enhancement?

PURPOSE: To determine how often a prescribed threshold of hepatic contrast material enhancement is not reached at helical computed tomography (CT) of the liver in patients in a tertiary teaching hospital-based practice and which variables are predictive of failure. MATERIALS AND METHODS: Hepatic helical CT was performed in 250 consecutive patients with computer-assisted bolus-tracking technology after either mechanical injection at 3 mL/sec (n = 177) or manual injection (n = 73) of 150 mL of iopamidol. Demographic variables were recorded. After 17 seconds, low-milliamperage monitoring scans were obtained every 6 seconds until hepatic enhancement of 50 HU over baseline was achieved. Time-enhancement curves were reviewed. RESULTS: The threshold was not reached by 60 seconds in 88 patients (35%; default group). The success and default groups were similar in most variables and differed only in weight (P = .002), patient status (inpatient, outpatient, or emergency department; P < .001), and injection type (mechanical vs manual; P < .001). Ten patients (4%) did not achieve the threshold because of inappropriate placement of elliptic regions of interest. CONCLUSION: By using computer-assisted bolus-tracking technology, 35% of patients in a tertiary teaching hospital-based practice will not achieve a threshold of 50 HU above baseline by 60 seconds after injection initiation and will require the use of a set delay. Failures are more frequent in patients who are heavy and in inpatients. No historic or demographic factors are strongly predictive of failure.

Adult↗